These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16203423)

  • 1. Australia's public health response to HIV and HCV: a role for 'affected' communities.
    Hulse GK
    Drug Alcohol Rev; 1997 Jun; 16(2):171-6. PubMed ID: 16203423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on Hulse's "Australia's public health response to HIV and HCV: a role for 'affected' communities".
    Blewett N; Stimson GV; Rhodes T; Bowtell B
    Drug Alcohol Rev; 1997 Jun; 16(2):177-81. PubMed ID: 16203424
    [No Abstract]   [Full Text] [Related]  

  • 3. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grassroots activities, national initiatives and HIV prevention: clues to explain Australia's dramatic early success in controlling the HIV epidemic.
    Plummer D; Irwin L
    Int J STD AIDS; 2006 Dec; 17(12):787-93. PubMed ID: 17212850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeking serenity: living with HIV/AIDS in rural Western Canada.
    Groft JN; Robinson Vollman A
    Rural Remote Health; 2007; 7(2):677. PubMed ID: 17516839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
    Sarkar K; Bal B; Mukherjee R; Chakraborty S; Niyogi SK; Saha MK; Bhattacharya SK
    Subst Use Misuse; 2006; 41(3):341-52. PubMed ID: 16467010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating HCV services for drug users: a model to improve engagement and outcomes.
    Sylvestre DL; Zweben JE
    Int J Drug Policy; 2007 Oct; 18(5):406-10. PubMed ID: 17854729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of religious groups to HIV/AIDS as a sexually transmitted infection in Trinidad.
    Genrich GL; Brathwaite BA
    BMC Public Health; 2005 Nov; 5():121. PubMed ID: 16288659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
    Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
    Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
    Doran E; Alexander Henry D
    J Public Health Policy; 2008 Apr; 29(1):106-20. PubMed ID: 18368023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.